Effects of COcoa Supplement in FRail Elderly Subjects (COFRE) (COFRE)
Primary Purpose
Sarcopenia, Frail Elderly Syndrome
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Placebo
Flavonoids
No Flavonoids
Sponsored by
About this trial
This is an interventional treatment trial for Sarcopenia focused on measuring flavonoids
Eligibility Criteria
Inclusion Criteria:
- Sex: both
- Age: 55-90 yo
- Waist circumference: Women > 80 cm, Men > 90 cm
- HDL-c: Women < 50 mg/dL, Men < 40 mg/dL
- Triglycerides: ≥ 150 mg/dL
- Glycemia: ≈100 mg/dL
- Hand strength: Women< 20 kg, Men < 30 kg
- Up & Go test: > 10 seconds
Non-inclusion criteria:
- Any active infections
- Malignancies
- Habitual consumers of antioxidant supplements and cocoa products
- Use of benzodiazepines or protein supplements
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Placebo Comparator
Sham Comparator
Experimental
Arm Label
Placebo
No Flavonoids
Flavonoids
Arm Description
Beverage without flavonoids
Beverage with alkalinized cocoa which eliminates flavonoid content
Beverage with a flavonoid rich mixture
Outcomes
Primary Outcome Measures
Blood glucose
Fasting blood level
Serum triacylglycerol concentration
Fasting blood level
Serum total cholesterol
Fasting blood level
Serum HDL cholesterol
Fasting blood level
Serum LDL cholesterol
Fasting blood level
Lipid oxidation
Serum malondialdehyde Levels
Protein oxidation
Serum protein carbonylation Levels
Secondary Outcome Measures
Handgrip strength
Measures static force in kilograms that the hand can squeeze around a dynamometer
Up and go test
Measures time in seconds, a subject can rise and walk a 3-meter line and return to sit down
Six-minute walk test
Measures maximum distance in meters, a subject can walk at their normal gait and pace during 6 minutes
Two-minute step in place test
Measures number of times a subject can rise each knee to the hip level during 2 minutes.
Sit-up test
Measures number of times a subject can rise and sit-down in place during 30 seconds
EQ-5D questionnaire
Self-administered health index that explores five domains
Analog Visual Scale
Use of a Analog Visual Scale to measure the quality of life, graded 0 (worst) to 100 (best) for the perception of wellbeing.
Full Information
NCT ID
NCT03585868
First Posted
May 16, 2018
Last Updated
July 12, 2018
Sponsor
National Polytechnic Institute, Mexico
1. Study Identification
Unique Protocol Identification Number
NCT03585868
Brief Title
Effects of COcoa Supplement in FRail Elderly Subjects (COFRE)
Acronym
COFRE
Official Title
Evaluation of the Effects of a COcoa Supplement to Reduce FRailty in the Elderly: COFRE a Randomized Clinical Trial
Study Type
Interventional
2. Study Status
Record Verification Date
July 2018
Overall Recruitment Status
Completed
Study Start Date
January 2017 (Actual)
Primary Completion Date
October 2017 (Actual)
Study Completion Date
December 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
National Polytechnic Institute, Mexico
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The study use a double blind, placebo-controlled design enrolling male and female subjects between 55-90 yo to evaluate the effect of daily consumption of a cocoa beverage on anthropometric, metabolic, oxidative stress, physical performance and quality of life.
Detailed Description
The study use a double blind, placebo-controlled design enrolling male and female subjects between 55-90 yo randomly assigned to consumption of a flavonoid rich mixture (flavonoids; F), alkalinized cocoa which eliminates flavonoid content (no flavonoids; NF) or placebo. All beverages had similar physical characteristics and flavor. Cocoa beverages were provided in individual sachets containing a dry powder that was reconstituted with water just before consumption. Subjects were instructed as above to maintain their usual lifestyle, to limit intake of high caloric foods and flavonoid-containing foods and beverages, and to walk for 30 min/day.
To determine the effect of flavonoids, study evaluates anthropometric measures, metabolic parameters as glycemia and a lipid profile (triglycerides, total cholesterol, high-density lipoprotein cholesterol and low-density lipoprotein cholesterol). To evaluate oxidative stress damage as lipid oxidation is measured with the malondialdehyde (MDA) assay. Protein carbonylation is measured using an assay for detection of carbonyl groups that relies on 2,4-dinitrophenylhydrazine (DNPH) as a substrate. The investigators also evaluate interleukin-6 and tumor necrosis factor levels.
For physical performance is evaluated the handgrip strength, and mobility assesment with the following test: Six-minute walk test, two-minute step, sit-up test and the up & go test.
The investigators also assessed quality of life using the Health Related QoL (EQ-5D) questionnaire.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sarcopenia, Frail Elderly Syndrome
Keywords
flavonoids
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
30 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Beverage without flavonoids
Arm Title
No Flavonoids
Arm Type
Sham Comparator
Arm Description
Beverage with alkalinized cocoa which eliminates flavonoid content
Arm Title
Flavonoids
Arm Type
Experimental
Arm Description
Beverage with a flavonoid rich mixture
Intervention Type
Other
Intervention Name(s)
Placebo
Intervention Description
Beverage with no flavonoids
Intervention Type
Other
Intervention Name(s)
Flavonoids
Intervention Description
Flavonoids-enriched cacao beverage
Intervention Type
Dietary Supplement
Intervention Name(s)
No Flavonoids
Intervention Description
Beverage with alkalinized cocoa which eliminates flavonoid content
Primary Outcome Measure Information:
Title
Blood glucose
Description
Fasting blood level
Time Frame
At 90 days
Title
Serum triacylglycerol concentration
Description
Fasting blood level
Time Frame
At 90 days
Title
Serum total cholesterol
Description
Fasting blood level
Time Frame
At 90 days
Title
Serum HDL cholesterol
Description
Fasting blood level
Time Frame
At 90 days
Title
Serum LDL cholesterol
Description
Fasting blood level
Time Frame
At 90 days
Title
Lipid oxidation
Description
Serum malondialdehyde Levels
Time Frame
At 90 days
Title
Protein oxidation
Description
Serum protein carbonylation Levels
Time Frame
At 90days
Secondary Outcome Measure Information:
Title
Handgrip strength
Description
Measures static force in kilograms that the hand can squeeze around a dynamometer
Time Frame
At 60 days
Title
Up and go test
Description
Measures time in seconds, a subject can rise and walk a 3-meter line and return to sit down
Time Frame
At 60 days
Title
Six-minute walk test
Description
Measures maximum distance in meters, a subject can walk at their normal gait and pace during 6 minutes
Time Frame
6 minutes
Title
Two-minute step in place test
Description
Measures number of times a subject can rise each knee to the hip level during 2 minutes.
Time Frame
2 minutes
Title
Sit-up test
Description
Measures number of times a subject can rise and sit-down in place during 30 seconds
Time Frame
30 seconds
Title
EQ-5D questionnaire
Description
Self-administered health index that explores five domains
Time Frame
At 60 days
Title
Analog Visual Scale
Description
Use of a Analog Visual Scale to measure the quality of life, graded 0 (worst) to 100 (best) for the perception of wellbeing.
Time Frame
At 60 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
55 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Sex: both
Age: 55-90 yo
Waist circumference: Women > 80 cm, Men > 90 cm
HDL-c: Women < 50 mg/dL, Men < 40 mg/dL
Triglycerides: ≥ 150 mg/dL
Glycemia: ≈100 mg/dL
Hand strength: Women< 20 kg, Men < 30 kg
Up & Go test: > 10 seconds
Non-inclusion criteria:
Any active infections
Malignancies
Habitual consumers of antioxidant supplements and cocoa products
Use of benzodiazepines or protein supplements
12. IPD Sharing Statement
Citations:
PubMed Identifier
31056655
Citation
Munguia L, Rubio-Gayosso I, Ramirez-Sanchez I, Ortiz A, Hidalgo I, Gonzalez C, Meaney E, Villarreal F, Najera N, Ceballos G. High Flavonoid Cocoa Supplement Ameliorates Plasma Oxidative Stress and Inflammation Levels While Improving Mobility and Quality of Life in Older Subjects: A Double-Blind Randomized Clinical Trial. J Gerontol A Biol Sci Med Sci. 2019 Sep 15;74(10):1620-1627. doi: 10.1093/gerona/glz107.
Results Reference
derived
Learn more about this trial
Effects of COcoa Supplement in FRail Elderly Subjects (COFRE)
We'll reach out to this number within 24 hrs